awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34172853-495EE153-9B52-4507-8CEA-BAD1ECECD89B
Q34172853-495EE153-9B52-4507-8CEA-BAD1ECECD89B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34172853-495EE153-9B52-4507-8CEA-BAD1ECECD89B
Phase III, multicenter, open-label, long-term study of the safety of abatacept in Japanese patients with rheumatoid arthritis and an inadequate response to conventional or biologic disease-modifying antirheumatic drugs.
P2860
Q34172853-495EE153-9B52-4507-8CEA-BAD1ECECD89B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34172853-495EE153-9B52-4507-8CEA-BAD1ECECD89B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
56aea892160f67b209d2c9d60f546fd925931210
P2860
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.